Ku70, an essential gene, modulates the frequency of rAAV-mediated gene targeting in human somatic cells

Farjana J. Fattah, Natalie F. Lichter, Kazi R. Fattah, Sehyun Oh, Eric A. Hendrickson

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Gene targeting has two important applications. One is the inactivation of genes ("knockouts"), and the second is the correction of a mutated allele back to wild-type ("gene therapy"). Central to these processes is the efficient introduction of the targeting DNA into the cells of interest. In humans, this targeting is often accomplished through the use of recombinant adeno-associated virus (rAAV). rAAV is presumed to use a pathway of DNA double-strand break (DSB) repair termed homologous recombination (HR) to mediate correct targeting; however, the specifics of this mechanism remain unknown. In this work, we attempted to generate Ku70-null human somatic cells by using a rAAV-based gene knockout strategy. Ku70 is the heterodimeric partner of Ku86, and together they constitute an end-binding activity that is required for a pathway [nonhomologous end joining (NHEJ)] of DSB repair that is believed to compete with HR. Our data demonstrated that Ku70 is an essential gene in human somatic cells. More importantly, however, in Ku70+/- cells, the frequency of gene targeting was 5-to 10-fold higher than in wild-type cells. RNA interference and short-hairpinned RNA strategies to deplete Ku70 phenocopied these results in wild-type cells and greatly accentuated them in Ku70 +/- cell lines. Thus, Ku70 protein levels significantly influenced the frequency of rAAV-mediated gene targeting in human somatic cells. Our data suggest that gene-targeting frequencies can be significantly improved in human cells by impairing the NHEJ pathway, and we propose that Ku70 depletion can be used to facilitate both knockout and gene therapy approaches.

Original languageEnglish (US)
Pages (from-to)8703-8708
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume105
Issue number25
DOIs
StatePublished - Jun 24 2008
Externally publishedYes

Fingerprint

Dependovirus
Gene Targeting
Essential Genes
Gene Frequency
Gene Knockout Techniques
Genetic Therapy
Recombinational DNA Repair
Double-Stranded DNA Breaks
Homologous Recombination
RNA Interference
Alleles
RNA
Cell Line
DNA

Keywords

  • DNA protein kinase
  • Gene therapy
  • Ku
  • Nonhomologous end joining (NHEJ)
  • Recombinant adeno-associated virus (rAAV)

ASJC Scopus subject areas

  • General

Cite this

Ku70, an essential gene, modulates the frequency of rAAV-mediated gene targeting in human somatic cells. / Fattah, Farjana J.; Lichter, Natalie F.; Fattah, Kazi R.; Oh, Sehyun; Hendrickson, Eric A.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, No. 25, 24.06.2008, p. 8703-8708.

Research output: Contribution to journalArticle

@article{b245fde5a9e342ed8ecbe2e07073ef91,
title = "Ku70, an essential gene, modulates the frequency of rAAV-mediated gene targeting in human somatic cells",
abstract = "Gene targeting has two important applications. One is the inactivation of genes ({"}knockouts{"}), and the second is the correction of a mutated allele back to wild-type ({"}gene therapy{"}). Central to these processes is the efficient introduction of the targeting DNA into the cells of interest. In humans, this targeting is often accomplished through the use of recombinant adeno-associated virus (rAAV). rAAV is presumed to use a pathway of DNA double-strand break (DSB) repair termed homologous recombination (HR) to mediate correct targeting; however, the specifics of this mechanism remain unknown. In this work, we attempted to generate Ku70-null human somatic cells by using a rAAV-based gene knockout strategy. Ku70 is the heterodimeric partner of Ku86, and together they constitute an end-binding activity that is required for a pathway [nonhomologous end joining (NHEJ)] of DSB repair that is believed to compete with HR. Our data demonstrated that Ku70 is an essential gene in human somatic cells. More importantly, however, in Ku70+/- cells, the frequency of gene targeting was 5-to 10-fold higher than in wild-type cells. RNA interference and short-hairpinned RNA strategies to deplete Ku70 phenocopied these results in wild-type cells and greatly accentuated them in Ku70 +/- cell lines. Thus, Ku70 protein levels significantly influenced the frequency of rAAV-mediated gene targeting in human somatic cells. Our data suggest that gene-targeting frequencies can be significantly improved in human cells by impairing the NHEJ pathway, and we propose that Ku70 depletion can be used to facilitate both knockout and gene therapy approaches.",
keywords = "DNA protein kinase, Gene therapy, Ku, Nonhomologous end joining (NHEJ), Recombinant adeno-associated virus (rAAV)",
author = "Fattah, {Farjana J.} and Lichter, {Natalie F.} and Fattah, {Kazi R.} and Sehyun Oh and Hendrickson, {Eric A.}",
year = "2008",
month = "6",
day = "24",
doi = "10.1073/pnas.0712060105",
language = "English (US)",
volume = "105",
pages = "8703--8708",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "25",

}

TY - JOUR

T1 - Ku70, an essential gene, modulates the frequency of rAAV-mediated gene targeting in human somatic cells

AU - Fattah, Farjana J.

AU - Lichter, Natalie F.

AU - Fattah, Kazi R.

AU - Oh, Sehyun

AU - Hendrickson, Eric A.

PY - 2008/6/24

Y1 - 2008/6/24

N2 - Gene targeting has two important applications. One is the inactivation of genes ("knockouts"), and the second is the correction of a mutated allele back to wild-type ("gene therapy"). Central to these processes is the efficient introduction of the targeting DNA into the cells of interest. In humans, this targeting is often accomplished through the use of recombinant adeno-associated virus (rAAV). rAAV is presumed to use a pathway of DNA double-strand break (DSB) repair termed homologous recombination (HR) to mediate correct targeting; however, the specifics of this mechanism remain unknown. In this work, we attempted to generate Ku70-null human somatic cells by using a rAAV-based gene knockout strategy. Ku70 is the heterodimeric partner of Ku86, and together they constitute an end-binding activity that is required for a pathway [nonhomologous end joining (NHEJ)] of DSB repair that is believed to compete with HR. Our data demonstrated that Ku70 is an essential gene in human somatic cells. More importantly, however, in Ku70+/- cells, the frequency of gene targeting was 5-to 10-fold higher than in wild-type cells. RNA interference and short-hairpinned RNA strategies to deplete Ku70 phenocopied these results in wild-type cells and greatly accentuated them in Ku70 +/- cell lines. Thus, Ku70 protein levels significantly influenced the frequency of rAAV-mediated gene targeting in human somatic cells. Our data suggest that gene-targeting frequencies can be significantly improved in human cells by impairing the NHEJ pathway, and we propose that Ku70 depletion can be used to facilitate both knockout and gene therapy approaches.

AB - Gene targeting has two important applications. One is the inactivation of genes ("knockouts"), and the second is the correction of a mutated allele back to wild-type ("gene therapy"). Central to these processes is the efficient introduction of the targeting DNA into the cells of interest. In humans, this targeting is often accomplished through the use of recombinant adeno-associated virus (rAAV). rAAV is presumed to use a pathway of DNA double-strand break (DSB) repair termed homologous recombination (HR) to mediate correct targeting; however, the specifics of this mechanism remain unknown. In this work, we attempted to generate Ku70-null human somatic cells by using a rAAV-based gene knockout strategy. Ku70 is the heterodimeric partner of Ku86, and together they constitute an end-binding activity that is required for a pathway [nonhomologous end joining (NHEJ)] of DSB repair that is believed to compete with HR. Our data demonstrated that Ku70 is an essential gene in human somatic cells. More importantly, however, in Ku70+/- cells, the frequency of gene targeting was 5-to 10-fold higher than in wild-type cells. RNA interference and short-hairpinned RNA strategies to deplete Ku70 phenocopied these results in wild-type cells and greatly accentuated them in Ku70 +/- cell lines. Thus, Ku70 protein levels significantly influenced the frequency of rAAV-mediated gene targeting in human somatic cells. Our data suggest that gene-targeting frequencies can be significantly improved in human cells by impairing the NHEJ pathway, and we propose that Ku70 depletion can be used to facilitate both knockout and gene therapy approaches.

KW - DNA protein kinase

KW - Gene therapy

KW - Ku

KW - Nonhomologous end joining (NHEJ)

KW - Recombinant adeno-associated virus (rAAV)

UR - http://www.scopus.com/inward/record.url?scp=47249150446&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47249150446&partnerID=8YFLogxK

U2 - 10.1073/pnas.0712060105

DO - 10.1073/pnas.0712060105

M3 - Article

C2 - 18562296

AN - SCOPUS:47249150446

VL - 105

SP - 8703

EP - 8708

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 25

ER -